» Articles » PMID: 37072854

Effects of an Asymmetrical High Flow Nasal Cannula Interface in Hypoxemic Patients

Overview
Journal Crit Care
Specialty Critical Care
Date 2023 Apr 19
PMID 37072854
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Optimal noninvasive respiratory support for patients with hypoxemic respiratory failure should minimize work of breathing without increasing the transpulmonary pressure. Recently, an asymmetrical high flow nasal cannula (HFNC) interface (Duet, Fisher & Paykel Healthcare Ltd), in which the caliber of each nasal prong is different, was approved for clinical use. This system might reduce work of breathing by lowering minute ventilation and improving respiratory mechanics.

Methods: We enrolled 10 patients ≥ 18 years of age who were admitted to the Ospedale Maggiore Policlinico ICU in Milan, Italy, and had a PaO/FiO < 300 mmHg during HFNC support with a conventional cannula. We investigated whether the asymmetrical interface, compared to a conventional high flow nasal cannula, reduces minute ventilation and work of breathing. Each patient underwent support with the asymmetrical interface and the conventional interface, applied in a randomized sequence. Each interface was provided at a flow rate of 40 l/min followed by 60 l/min. Patients were continuously monitored with esophageal manometry and electrical impedance tomography.

Results: Application of the asymmetrical interface resulted in a -13.5 [-19.4 to (-4.5)] % change in minute ventilation at a flow rate of 40 l/min, p = 0.006 and a -19.6 [-28.0 to (-7.5)] % change at 60 l/min, p = 0.002, that occurred despite no change in PaCO (35 [33-42] versus 35 [33-43] mmHg at 40 l/min and 35 [32-41] versus 36 [32-43] mmHg at 60 l/min). Correspondingly, the asymmetrical interface lowered the inspiratory esophageal pressure-time product from 163 [118-210] to 140 [84-159] (cmHO*s)/min at a flow rate of 40 l/min, p = 0.02 and from 142 [123-178] to 117 [90-137] (cmHO*s)/min at a flow rate of 60 l/min, p = 0.04. The asymmetrical cannula did not have any impact on oxygenation, the dorsal fraction of ventilation, dynamic lung compliance, or end-expiratory lung impedance, suggesting no major effect on PEEP, lung mechanics, or alveolar recruitment.

Conclusions: An asymmetrical HFNC interface reduces minute ventilation and work of breathing in patients with mild-to-moderate hypoxemic respiratory failure supported with a conventional interface. This appears to be primarily driven by increased ventilatory efficiency due to enhanced CO clearance from the upper airway.

Citing Articles

Effect of Single-Prong Cannula Design With High Velocity Therapy: Comparable Efficacy at Lower Gas Flow Rates.

Atwood C, Sethi J, Bergeski A, Dungan 2nd G, Volakis L, Whittle J Crit Care Explor. 2025; 7(2):e1209.

PMID: 39937568 PMC: 11826042. DOI: 10.1097/CCE.0000000000001209.


Airway pressures generated by high flow nasal cannula in patients with acute hypoxemic respiratory failure: a computational study.

Shamohammadi H, Weaver L, Saffaran S, Tonelli R, Laviola M, Laffey J Respir Res. 2025; 26(1):9.

PMID: 39780218 PMC: 11715915. DOI: 10.1186/s12931-025-03096-x.


High-Flow Nasal Oxygen in Patients with Acute Hypercapnic Respiratory Failure: A Narrative Review of the Physiological Rationale and Clinical Evidence.

Pintaudi G, Cutuli S, Rosa T, Michi T, Cardu A, Bongiovanni F J Clin Med. 2024; 13(21).

PMID: 39518490 PMC: 11546100. DOI: 10.3390/jcm13216350.


Clinical review of non-invasive ventilation.

Criner G, Gayen S, Zantah M, Dominguez Castillo E, Naranjo M, Lashari B Eur Respir J. 2024; 64(5).

PMID: 39227076 PMC: 11540995. DOI: 10.1183/13993003.00396-2024.


High-flow nasal cannula: evolving practices and novel clinical and physiological insights.

Roca O, Li J, Mauri T Intensive Care Med. 2024; 50(5):758-761.

PMID: 38573402 DOI: 10.1007/s00134-024-07386-8.


References
1.
Rochwerg B, Einav S, Chaudhuri D, Mancebo J, Mauri T, Helviz Y . The role for high flow nasal cannula as a respiratory support strategy in adults: a clinical practice guideline. Intensive Care Med. 2020; 46(12):2226-2237. PMC: 7670292. DOI: 10.1007/s00134-020-06312-y. View

2.
Grieco D, Maggiore S, Roca O, Spinelli E, Patel B, Thille A . Non-invasive ventilatory support and high-flow nasal oxygen as first-line treatment of acute hypoxemic respiratory failure and ARDS. Intensive Care Med. 2021; 47(8):851-866. PMC: 8261815. DOI: 10.1007/s00134-021-06459-2. View

3.
Mauri T, Wang Y, Dalla Corte F, Corcione N, Spinelli E, Pesenti A . Nasal high flow: physiology, efficacy and safety in the acute care setting, a narrative review. Open Access Emerg Med. 2019; 11:109-120. PMC: 6549413. DOI: 10.2147/OAEM.S180197. View

4.
Rochwerg B, Granton D, Wang D, Helviz Y, Einav S, Frat J . High flow nasal cannula compared with conventional oxygen therapy for acute hypoxemic respiratory failure: a systematic review and meta-analysis. Intensive Care Med. 2019; 45(5):563-572. DOI: 10.1007/s00134-019-05590-5. View

5.
Mauri T, Turrini C, Eronia N, Grasselli G, Volta C, Bellani G . Physiologic Effects of High-Flow Nasal Cannula in Acute Hypoxemic Respiratory Failure. Am J Respir Crit Care Med. 2016; 195(9):1207-1215. DOI: 10.1164/rccm.201605-0916OC. View